Development and Validation of a Clinical Scoring System for Predicting Risk of HCC in Asymptomatic Individuals Seropositive for Anti-HCV Antibodies

BACKGROUND: The development of a risk assessment tool for long-term hepatocellular carcinoma risk would be helpful in identifying high-risk patients and providing information of clinical consultation. METHODS: The model derivation and validation cohorts consisted of 975 and 572 anti-HCV seropositive...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Mei-Hsuan, Lu, Sheng-Nan, Yuan, Yong, Yang, Hwai-I, Jen, Chin-Lan, You, San-Lin, Wang, Li-Yu, L'Italien, Gilbert, Chen, Chien-Jen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4011690/
https://www.ncbi.nlm.nih.gov/pubmed/24801353
http://dx.doi.org/10.1371/journal.pone.0094760

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4011690/
https://www.ncbi.nlm.nih.gov/pubmed/24801353
http://dx.doi.org/10.1371/journal.pone.0094760

Ejemplares similares